Cell No. : Cell Name
RCB0540 : HAL-01 update : 2022/03/17 |
||||
Comment | Acute lymphatic leukemia | |||
Comment from the depositor | ||||
Terms and conditions | A prior written permission of the approver(Depositor) is necessary for any kind of use including academic use and for-profit use. | |||
Remarks | ||||
approver's address |
×
|
|||
Order Form | Order Form(C-0005.pdf)   Approval Form(C-0006.pdf)   MTA(C-0007.pdf)   MTA(C-0007p.pdf)   | |||
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp). | ||||
Basic information | Depositor | Ohyashiki, Kazuma | ||
Originator | Ohyashiki, Kazuma | |||
Year of deposit | 1990 | |||
Animal | human < Mammals | |||
Genus | Homo | |||
Species | sapiens | |||
Race | Japanese | |||
Gender | Female | |||
Age at sampling | 17 years | |||
Tissue | blood | |||
Disease name | acute lymphatic leukemia | |||
Classification | cancer | |||
Year of origin | 1989 | Lifespan | infinite | |
Morphology | lymphocyte-like | |||
Cellosaurus(Expasy) | CVCL_1242 | |||
Medium | Medium List | Culture type | Suspension cells | |
Medium and additives | RPMI1640 + 15% FBS | |||
Antibiotics | Free | Passage method | dilution | Culture information | Passage ratio | 1 : 4 split |
SC frequency | Subculture : 2 times/week | |||
Temperature | 37 ℃ | |||
CO2 concentration | 5 % | |||
Freeze medium | Medium + 10% DMSO | |||
Freezing method | Slow freezing | |||
Mycoplasma | (-) | |||
Virus (HIV) | (-) | |||
Virus (HTLV-1) | (-) | |||
Isozyme | LD, NP | |||
Chromosome mode | 40-47(50) : /42(3),43(3),44(3),45(14),46(21),47(4) | |||
STR(human) | OK | |||
Images | ||||
|
|
|||
Reference information | Reference | 1 | ||
User's Publication | 3 | |||